会议专题

Validating New Molecular Assays Considerations in Choosing a Platform and Validation Process

Molecular Testing and Applications Molecular profiling Risk assessment Risk management Micro-RNAs Somatic/driver mutations Susceptibility genes Methylation Epigenetic changes Prediction of therapeutic response Prognosis Therapeutic monitoring Patient stratification Alterations in gene expression

Maria E.Arcila MD

Molecular Hematopathology Memorial Sloan Kettering Cancer center

国内会议

第六届肿瘤分子病理检测标准化应用及质量控制研讨会

上海

英文

1-14

2017-07-28(万方平台首次上网日期,不代表论文的发表时间)